Acquired

Navigenics Stock

Personal genomics

Sign up today and learn more about Navigenics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Navigenics Stock

Navigenics, Inc. helps educate and empower individuals and their physicians with knowledge of their genetic predispositions, and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact. Navigenics' lead investors are Kleiner Perkins Caufield and Byers, Sequoia Capital and MDV-Mohr Davidow Ventures.

Funding History

2007-11-01$25.0M
2010-02-01$18.0M

Management

Co-Founder

David B. Agus

Co-Founder, Chief Science officer

Dietrich Stephan

CEO

Vance Vanier

CFO

Matthew Garrett

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo